Cargando…

Inhibition of the reward system by antipsychotic treatment

The mesolimbic dopaminergic reward system is responsible for the negative affective symptomatology of schizophrenia, which may be related to a low dopamine tonus within the ventral striatum. The monetary incentive delay (MID) task can be used to study the response of the ventral striatum to incentiv...

Descripción completa

Detalles Bibliográficos
Autor principal: Juckel, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Les Laboratoires Servier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826766/
https://www.ncbi.nlm.nih.gov/pubmed/27069385
_version_ 1782426372740743168
author Juckel, Georg
author_facet Juckel, Georg
author_sort Juckel, Georg
collection PubMed
description The mesolimbic dopaminergic reward system is responsible for the negative affective symptomatology of schizophrenia, which may be related to a low dopamine tonus within the ventral striatum. The monetary incentive delay (MID) task can be used to study the response of the ventral striatum to incentive stimuli. We show that activation of the ventral striatum is low in patients with schizophrenia, and that this low activation is related to primary and secondary negative symptoms induced by neuroleptics, also known as antipsychotics. Switching from first-(typical) to second-generation (atypical) antipsychotics increased activation of the ventral striatum due to less blocking of dopamine D2 receptors. This and similar studies show that functional magnetic resonance imaging (fMRI) tasks are suitable to investigate important aspects of antipsychotic mechanisms.
format Online
Article
Text
id pubmed-4826766
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Les Laboratoires Servier
record_format MEDLINE/PubMed
spelling pubmed-48267662016-04-11 Inhibition of the reward system by antipsychotic treatment Juckel, Georg Dialogues Clin Neurosci Pharmacological Aspects The mesolimbic dopaminergic reward system is responsible for the negative affective symptomatology of schizophrenia, which may be related to a low dopamine tonus within the ventral striatum. The monetary incentive delay (MID) task can be used to study the response of the ventral striatum to incentive stimuli. We show that activation of the ventral striatum is low in patients with schizophrenia, and that this low activation is related to primary and secondary negative symptoms induced by neuroleptics, also known as antipsychotics. Switching from first-(typical) to second-generation (atypical) antipsychotics increased activation of the ventral striatum due to less blocking of dopamine D2 receptors. This and similar studies show that functional magnetic resonance imaging (fMRI) tasks are suitable to investigate important aspects of antipsychotic mechanisms. Les Laboratoires Servier 2016-03 /pmc/articles/PMC4826766/ /pubmed/27069385 Text en Copyright: © 2016 Institut la Conférence Hippocrate - Servier Research Group http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Pharmacological Aspects
Juckel, Georg
Inhibition of the reward system by antipsychotic treatment
title Inhibition of the reward system by antipsychotic treatment
title_full Inhibition of the reward system by antipsychotic treatment
title_fullStr Inhibition of the reward system by antipsychotic treatment
title_full_unstemmed Inhibition of the reward system by antipsychotic treatment
title_short Inhibition of the reward system by antipsychotic treatment
title_sort inhibition of the reward system by antipsychotic treatment
topic Pharmacological Aspects
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826766/
https://www.ncbi.nlm.nih.gov/pubmed/27069385
work_keys_str_mv AT juckelgeorg inhibitionoftherewardsystembyantipsychotictreatment